Suppr超能文献

院内高血糖而非单纯糖尿病与社区获得性肺炎(CAP)住院死亡率增加相关:COVID-19 前观察性研究的系统评价和荟萃分析。

In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19.

机构信息

Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Parkville, Victoria, Australia

Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.

出版信息

BMJ Open Diabetes Res Care. 2022 Jul;10(4). doi: 10.1136/bmjdrc-2022-002880.

Abstract

The objective of this review was to quantify the association between diabetes, hyperglycemia, and outcomes in patients hospitalized for community-acquired pneumonia (CAP) prior to the COVID-19 pandemic by conducting a systematic review and meta-analysis. Two investigators independently screened records identified in the PubMed (MEDLINE), EMBASE, CINAHL, and Web of Science databases. Cohort and case-control studies quantitatively evaluating associations between diabetes and in-hospital hyperglycemia with outcomes in adults admitted to hospital with CAP were included. Quality was assessed using the Newcastle-Ottawa Quality Assessment Scale, effect size using random-effects models, and heterogeneity using I statistics. Thirty-eight studies met the inclusion criteria. Hyperglycemia was associated with in-hospital mortality (adjusted OR 1.28, 95% CI 1.09 to 1.50) and intensive care unit (ICU) admission (crude OR 1.82, 95% CI 1.17 to 2.84). There was no association between diabetes status and in-hospital mortality (adjusted OR 1.04, 95% CI 0.72 to 1.51), 30-day mortality (adjusted OR 1.13, 95% CI 0.77 to 1.67), or ICU admission (crude OR 1.91, 95% CI 0.74 to 4.95). Diabetes was associated with increased mortality in all studies reporting >90-day postdischarge mortality and with longer length of stay only for studies reporting crude (OR 1.50, 95% CI 1.11 to 2.01) results. In adults hospitalized with CAP, in-hospital hyperglycemia but not diabetes alone is associated with increased in-hospital mortality and ICU admission. Diabetes status is associated with increased >90-day postdischarge mortality. Implications for management are that in-hospital hyperglycemia carries a greater risk for in-hospital morbidity and mortality than diabetes alone in patients admitted with non-COVID-19 CAP. Evaluation of strategies enabling timely and effective management of in-hospital hyperglycemia in CAP is warranted.

摘要

本综述的目的是通过系统评价和荟萃分析,量化糖尿病、高血糖与 COVID-19 大流行前社区获得性肺炎(CAP)住院患者结局之间的关系。两位研究者独立筛选了在 PubMed(MEDLINE)、EMBASE、CINAHL 和 Web of Science 数据库中识别出的记录。纳入了定量评估糖尿病和住院高血糖与成人因 CAP 住院患者住院期间结局之间关系的队列研究和病例对照研究。使用纽卡斯尔-渥太华质量评估量表评估质量,使用随机效应模型评估效应大小,使用 I 统计量评估异质性。38 项研究符合纳入标准。高血糖与住院死亡率(校正比值比 1.28,95%置信区间 1.09 至 1.50)和重症监护病房(ICU)入住(未校正比值比 1.82,95%置信区间 1.17 至 2.84)相关。糖尿病与住院死亡率(校正比值比 1.04,95%置信区间 0.72 至 1.51)、30 天死亡率(校正比值比 1.13,95%置信区间 0.77 至 1.67)或 ICU 入住(未校正比值比 1.91,95%置信区间 0.74 至 4.95)无关。在所有报告出院后 >90 天死亡率的研究中,糖尿病与死亡率增加相关,而在仅报告未校正(OR 1.50,95%CI 1.11 至 2.01)结果的研究中,糖尿病与住院时间延长相关。在因 CAP 住院的成年人中,住院期间高血糖而不是单纯的糖尿病与住院期间死亡率和 ICU 入住增加相关。糖尿病状态与 >90 天出院后死亡率增加相关。这对管理的启示是,与单纯糖尿病相比,住院期间高血糖与 COVID-19 非 CAP 住院患者住院期间发病率和死亡率增加的相关性更大。需要评估能够及时有效地管理 CAP 患者住院期间高血糖的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d1/9257863/75ef99dbf1f0/bmjdrc-2022-002880f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验